Aquarius Surgical Technologies Inc.
AQQRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $6 | $4 | $4 | $1 |
| Enterprise Value | $7 | $4 | $4 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | 0.7% | -37.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 51.9% | 64.7% | 36.4% | 24.2% |
| EBITDA | -$1 | -$0 | -$1 | -$1 |
| % Margin | -913.1% | -209.4% | -253.9% | -194.2% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,279.8% | -369.1% | -355.1% | -262.2% |
| EPS Diluted | -0.04 | -0.028 | -0.029 | -0.037 |
| % Growth | -45.5% | 5.5% | 21.8% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |